Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 146 participants.
Also called NCT04591808
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 146 participants
- Sponsor
- Institut de Recherches Internationales Servier
- Registry
-
NCT04591808
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Georgia, Russia, Ukraine
- Registry status
- Terminated
Technical summary
Registry record NCT04591808. Randomized; double masking; primary purpose treatment. Start 2021-09-09 (actual); primary completion 2022-04-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
- Condition
- Dyslipidemias
- Condition
- Hypertension
- Intervention (Drug)
- Atorvastatin/Perindopril
- Intervention (Drug)
- Atorvastatin
- Intervention (Drug)
- Perindopril
- Lead sponsor
- Institut de Recherches Internationales Servier
- Collaborator
- ADIR, a Servier Group company
Record details
- Record id
cardio:ct-nct04591808- Content hash
0fd9490137ae334abb8f83ab4ad43a36b44d7fca693af3987983050d3409e84f